What is Collegium Pharmaceutical, Inc.'s PP&E (net)?

Collegium Pharmaceutical, Inc. (COLL) reported PP&E (net) of $11.66M in Q1 2026.

How has Collegium Pharmaceutical, Inc.'s PP&E (net) changed year-over-year?

Collegium Pharmaceutical, Inc.'s PP&E (net) decreased by 15.8% year-over-year, from $13.85M to $11.66M.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s PP&E (net) has grown at a -8.7% compound annual growth rate (CAGR), from $18.99M to $12.01M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Collegium Pharmaceutical, Inc. COLL PP&E (Net)

PP&E (Net) at other companies

Indivior Pharmaceuticals, Inc. INDV

$157M+51.0%

Catalyst PharmaceuticalCPRX

$994K-19.8%

Avanos MedicalAVNS

$111.2M+1.3%

Pacira BioSciences, Inc.PCRX

$136.28M-17.1%

Supernus PharmaceuticalsSUPN

$10.04M-11.4%

Theravance BiopharmaTBPH

$5.54M-21.2%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+9.5%

Enterprise value$869.67M-9.8%

P/E15.4×-8.6×

P/S1.5×-0.1×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s PP&E (net)?: Collegium Pharmaceutical, Inc. (COLL) reported PP&E (net) of $11.66M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s PP&E (net) changed year-over-year?: Collegium Pharmaceutical, Inc.'s PP&E (net) decreased by 15.8% year-over-year, from $13.85M to $11.66M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s PP&E (net) has grown at a -8.7% compound annual growth rate (CAGR), from $18.99M to $12.01M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.